Skip to main content

Peer Review reports

From: Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients

Original Submission
29 Jan 2021 Submitted Original manuscript
3 Feb 2021 Reviewed Reviewer Report
22 Feb 2021 Reviewed Reviewer Report
8 Apr 2021 Author responded Author comments - Yong Zou
9 Apr 2021 Author responded Author comments - Yong Zou
Resubmission - Version 2
8 Apr 2021 Submitted Manuscript version 2
12 Apr 2021 Reviewed Reviewer Report
23 Apr 2021 Reviewed Reviewer Report
24 May 2021 Author responded Author comments - Yong Zou
Resubmission - Version 3
24 May 2021 Submitted Manuscript version 3
25 May 2021 Author responded Author comments - Yong Zou
Resubmission - Version 4
25 May 2021 Submitted Manuscript version 4
25 May 2021 Reviewed Reviewer Report
22 Jun 2021 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
27 Jul 2021 Editorially accepted
4 Aug 2021 Article published 10.1186/s12876-021-01887-2

You can find further information about peer review here.

Back to article page